Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SUN bioscience has developed and commercialized the Gri3D® high-throughput microwell plate system that enables robust and scalable generation of standardized organoids from patient-derived or pluripotent stem cells. Their technology addresses key challenges in reproducibility and scalability of organoid cultures. The company collaborates with academic institutions globally but does not itself conduct clinical trials or develop therapeutic drugs directly. Their products are used as advanced preclinical models for drug discovery and personalized medicine applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SUN bioscience.